CLDX - Celldex Therapeutics, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5348.45M
Enterprise Value 3209.02M
Trailing P/E N/A
Forward P/E 1-3.29
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)27.34
Price/Book (mrq)1.45
Enterprise Value/Revenue 316.40
Enterprise Value/EBITDA 6-2.01

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)-857.94%

Management Effectiveness

Return on Assets (ttm)-19.55%
Return on Equity (ttm)-37.08%

Income Statement

Revenue (ttm)12.74M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)84.50%
Gross Profit (ttm)12.74M
EBITDA -104.02M
Net Income Avi to Common (ttm)-93.03M
Diluted EPS (ttm)-0.72
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)139.43M
Total Cash Per Share (mrq)0.99
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.22
Book Value Per Share (mrq)1.71

Cash Flow Statement

Operating Cash Flow (ttm)-99.93M
Levered Free Cash Flow (ttm)-59.52M

Trading Information

Stock Price History

Beta 2.53
52-Week Change 3-26.11%
S&P500 52-Week Change 315.75%
52 Week High 33.75
52 Week Low 32.20
50-Day Moving Average 32.49
200-Day Moving Average 32.73

Share Statistics

Avg Vol (3 month) 31.34M
Avg Vol (10 day) 32.01M
Shares Outstanding 5141.07M
Float 140.43M
% Held by Insiders 10.59%
% Held by Institutions 157.34%
Shares Short 37.89M
Short Ratio 35.82
Short % of Float 37.50%
Shares Short (prior month) 37.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/12
Last Split Date 3Mar 10, 2008